Back to search
Restrictive Chronic Lung Allograft Dysfunction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Restrictive Chronic Lung Allograft Dysfunction trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Restrictive Chronic Lung Allograft Dysfunction trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is for people who have had a lung transplant and developed a condition called chronic lung allograft dysfunction (CLAD), which is a type of chronic r…
Despite advances in lung transplantation, the median survival remains only 55% at 5 years. The main limitation to long term survival is the development of chron…
A controlled randomized, open-label, multi-centre study evaluating if an immunosuppressive protocol, based on ATG-induction, once daily tacrolimus-dose (Advagra…
While many patients experience benefits from transplant, complications such as infections and lung rejection may affect long term survival and quality of life.…